Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1961 3
1962 1
1963 3
1965 10
1966 3
1967 2
1968 6
1969 7
1970 3
1971 10
1972 4
1973 3
1975 3
1977 3
1978 3
1979 6
1980 3
1982 4
1983 3
1984 4
1985 2
1986 4
1987 2
1988 4
1989 10
1990 4
1991 6
1992 6
1993 7
1994 8
1995 5
1996 1
1997 7
1998 5
1999 10
2000 9
2001 7
2002 16
2003 22
2004 21
2005 12
2006 18
2007 15
2008 18
2009 22
2010 19
2011 20
2012 24
2013 28
2014 26
2015 23
2016 30
2017 31
2018 42
2019 29
2020 59
2021 53
2022 34
2023 46
2024 42
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

747 results

Results by year

Filters applied: . Clear all
Page 1
Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study.
Miyake H, Matsumoto R, Fujimoto K, Mizokami A, Uemura H, Kamoto T, Kawakami S, Nakamura K, Maekawa S, Shibayama K, Watanabe A, Ito M, Tajima Y, Matsuyama H, Uemura H. Miyake H, et al. Among authors: matsuyama h. Eur Urol Oncol. 2024 Jun;7(3):625-632. doi: 10.1016/j.euo.2023.12.013. Epub 2024 Jan 30. Eur Urol Oncol. 2024. PMID: 38296736 Free article.
Editorial Comment from Dr Sakano and Dr Matsuyama to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
Sakano S, Matsuyama H. Sakano S, et al. Among authors: matsuyama h. Int J Urol. 2016 Mar;23(3):231-2. doi: 10.1111/iju.13057. Epub 2016 Jan 28. Int J Urol. 2016. PMID: 26822627 No abstract available.
Clinical Characteristics of Corynebacterium ulcerans Infection, Japan.
Yamamoto A, Hifumi T, Ato M, Iwaki M, Senoh M, Hatanaka A, Nureki S, Noguchi Y, Hirose T, Yoshimura Y, Urakawa T, Hori S, Nakada H, Terada T, Ishifuji T, Matsuyama H, Kinebuchi T, Fukushima A, Wake K, Otsuji K, Endo T, Toyoshima H, Yasuda I, Tanaka T, Takahashi N, Okada K, Hayashi T, Kusano T, Koriyama M, Otani N, Takahashi M. Yamamoto A, et al. Among authors: matsuyama h. Emerg Infect Dis. 2023 Aug;29(8):1505-15. doi: 10.3201/eid2908.220058. Emerg Infect Dis. 2023. PMID: 37486266 Free PMC article. Review.
Mesalazine-induced eosinophilic pneumonia.
Tanigawa K, Sugiyama K, Matsuyama H, Nakao H, Kohno K, Komuro Y, Iwanaga Y, Eguchi K, Kitaichi M, Takagi H. Tanigawa K, et al. Among authors: matsuyama h. Respiration. 1999;66(1):69-72. doi: 10.1159/000029341. Respiration. 1999. PMID: 9973695 Review.
When self-assembly meets interfacial polymerization.
Shen Q, Song Q, Mai Z, Lee KR, Yoshioka T, Guan K, Gonzales RR, Matsuyama H. Shen Q, et al. Among authors: matsuyama h. Sci Adv. 2023 May 3;9(18):eadf6122. doi: 10.1126/sciadv.adf6122. Epub 2023 May 3. Sci Adv. 2023. PMID: 37134177 Free PMC article.
MicroRNA regulons in tumor microenvironment.
Suzuki HI, Katsura A, Matsuyama H, Miyazono K. Suzuki HI, et al. Among authors: matsuyama h. Oncogene. 2015 Jun 11;34(24):3085-94. doi: 10.1038/onc.2014.254. Epub 2014 Aug 18. Oncogene. 2015. PMID: 25132266 Free PMC article. Review.
The Functional Role of Group 2 Innate Lymphoid Cells in Asthma.
Matsuyama T, Machida K, Mizuno K, Matsuyama H, Dotake Y, Shinmura M, Takagi K, Inoue H. Matsuyama T, et al. Among authors: matsuyama h. Biomolecules. 2023 May 26;13(6):893. doi: 10.3390/biom13060893. Biomolecules. 2023. PMID: 37371472 Free PMC article. Review.
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401.
Yokomizo A, Shiota M, Morokuma F, Eto M, Matsuyama H, Matsumoto H, Kamoto T, Terada N, Kawahara K, Enokida H, Tatarano S, Fujimoto N, Higasijima K, Sakai H, Hakariya T, Igawa T, Suekane S, Kamba T, Sugiyama Y, Kishimoto J, Naito S. Yokomizo A, et al. Among authors: matsuyama h. Int J Urol. 2024 Apr;31(4):362-369. doi: 10.1111/iju.15371. Epub 2023 Dec 26. Int J Urol. 2024. PMID: 38148124 Clinical Trial.
747 results